Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel D Joyce

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Urology|October 30, 2024
Editorial CommentDaniel D Joyce
Urology|April 9, 2025
Editorial Comment on "Real-World Economic Burden and Healthcare Resource Utilization of Radical Cystectomy and Trimodal Therapy for Bladder Cancer in the United States"Daniel D Joyce
Urology Practice|October 25, 2024
Editorial CommentaryDaniel D Joyce
The Journal of Urology|March 17, 2025
Time to Rethink Gleason GradingDaniel D Joyce, Jeffrey J Tosoian
The Journal of Urology|August 14, 2025
Shared Decision-Making in Prostate Cancer Management: Easy to Say, Hard to MeasureDaniel D Joyce, D Robert Siemens
JACC. Heart Failure|April 12, 2014
Are centrifugal ventricular assist devices the answer to reducing post-implantation gastrointestinal bleeding?Sheri S Crow, Daniel D Joyce
Urologic Oncology|April 7, 2023
Financial toxicity of oral therapies in advanced prostate cancerDaniel D Joyce, Stacie B Dusetzina
The Journal of Urology|December 11, 2025
Editorial CommentRandie E White, Daniel D Joyce
Pharmacoeconomics|April 23, 2023
Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the LiteratureDaniel D Joyce, Vidit Sharma, Stephen B Williams
Annals of Internal Medicine|June 3, 2024
The Cost-Effectiveness of Prostate Cancer Screening That Incorporates Magnetic Resonance ImagingDaniel D Joyce, Ruchika Talwar, Kelvin A Moses
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Urology|October 30, 2024
Editorial CommentDaniel D Joyce
Urology|April 9, 2025
Editorial Comment on "Real-World Economic Burden and Healthcare Resource Utilization of Radical Cystectomy and Trimodal Therapy for Bladder Cancer in the United States"Daniel D Joyce
Urology Practice|October 25, 2024
Editorial CommentaryDaniel D Joyce
The Journal of Urology|March 17, 2025
Time to Rethink Gleason GradingDaniel D Joyce, Jeffrey J Tosoian
The Journal of Urology|August 14, 2025
Shared Decision-Making in Prostate Cancer Management: Easy to Say, Hard to MeasureDaniel D Joyce, D Robert Siemens
JACC. Heart Failure|April 12, 2014
Are centrifugal ventricular assist devices the answer to reducing post-implantation gastrointestinal bleeding?Sheri S Crow, Daniel D Joyce
Urologic Oncology|April 7, 2023
Financial toxicity of oral therapies in advanced prostate cancerDaniel D Joyce, Stacie B Dusetzina
The Journal of Urology|December 11, 2025
Editorial CommentRandie E White, Daniel D Joyce
Pharmacoeconomics|April 23, 2023
Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the LiteratureDaniel D Joyce, Vidit Sharma, Stephen B Williams
Annals of Internal Medicine|June 3, 2024
The Cost-Effectiveness of Prostate Cancer Screening That Incorporates Magnetic Resonance ImagingDaniel D Joyce, Ruchika Talwar, Kelvin A Moses
Pageof 6